Lowering FDA’s Drug-Approval Standards Is a Lose-Lose

(MedPage Today) — Last week, FDA Commissioner Marty Makary, MD, MPH, announced plans to officially lower the standard for how many clinical trials are needed to approve a new drug — from the long-standing expectation of at least two trials…